193 related articles for article (PubMed ID: 22482716)
1. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection.
McMinn PC
Curr Opin Virol; 2012 Apr; 2(2):199-205. PubMed ID: 22482716
[TBL] [Abstract][Full Text] [Related]
2. EV71: an emerging infectious disease vaccine target in the Far East?
Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
[TBL] [Abstract][Full Text] [Related]
3. The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development.
Chang PC; Chen SC; Chen KT
Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27618078
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses.
van der Sanden S; van der Avoort H; Lemey P; Uslu G; Koopmans M
J Gen Virol; 2010 Aug; 91(Pt 8):1949-1958. PubMed ID: 20375223
[TBL] [Abstract][Full Text] [Related]
5. Evolution of re-emergent virus and its impact on enterovirus 71 epidemics.
Huang SW; Kiang D; Smith DJ; Wang JR
Exp Biol Med (Maywood); 2011 Aug; 236(8):899-908. PubMed ID: 21715436
[TBL] [Abstract][Full Text] [Related]
6. Development of enterovirus 71 vaccines.
Lee MS; Chang LY
Expert Rev Vaccines; 2010 Feb; 9(2):149-56. PubMed ID: 20109026
[TBL] [Abstract][Full Text] [Related]
7. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
8. Human enterovirus 71 strains in the background population and in hospital patients in Finland.
Honkanen H; Oikarinen S; Pakkanen O; Ruokoranta T; Pulkki MM; Laitinen OH; Tauriainen S; Korpela S; Lappalainen M; Vuorinen T; Haapala AM; Veijola R; Simell O; Ilonen J; Knip M; Hyöty H
J Clin Virol; 2013 Apr; 56(4):348-53. PubMed ID: 23261080
[TBL] [Abstract][Full Text] [Related]
9. Diseases caused by enterovirus 71 infection.
Lee TC; Guo HR; Su HJ; Yang YC; Chang HL; Chen KT
Pediatr Infect Dis J; 2009 Oct; 28(10):904-10. PubMed ID: 20118685
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community.
Sanders SA; Herrero LJ; McPhie K; Chow SS; Craig ME; Dwyer DE; Rawlinson W; McMinn PC
Arch Virol; 2006 May; 151(5):1003-13. PubMed ID: 16369861
[TBL] [Abstract][Full Text] [Related]
11. Detection of recombination breakpoints in the genomes of human enterovirus 71 strains isolated in the Netherlands in epidemic and non-epidemic years, 1963-2010.
van der Sanden S; van Eek J; Martin DP; van der Avoort H; Vennema H; Koopmans M
Infect Genet Evol; 2011 Jul; 11(5):886-94. PubMed ID: 21352955
[TBL] [Abstract][Full Text] [Related]
12. Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection.
Bek EJ; Hussain KM; Phuektes P; Kok CC; Gao Q; Cai F; Gao Z; McMinn PC
Vaccine; 2011 Jun; 29(29-30):4829-38. PubMed ID: 21550375
[TBL] [Abstract][Full Text] [Related]
13. The enterovirus 71 epidemic in 2008--public health implications for Hong Kong.
Ma E; Chan KC; Cheng P; Wong C; Chuang SK
Int J Infect Dis; 2010 Sep; 14(9):e775-80. PubMed ID: 20599410
[TBL] [Abstract][Full Text] [Related]
14. Genetic evolution of enterovirus 71: epidemiological and pathological implications.
Bible JM; Pantelidis P; Chan PK; Tong CY
Rev Med Virol; 2007; 17(6):371-9. PubMed ID: 17487831
[TBL] [Abstract][Full Text] [Related]
15. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL
Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888
[TBL] [Abstract][Full Text] [Related]
16. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge.
Pérez-Vélez CM; Anderson MS; Robinson CC; McFarland EJ; Nix WA; Pallansch MA; Oberste MS; Glodé MP
Clin Infect Dis; 2007 Oct; 45(8):950-7. PubMed ID: 17879907
[TBL] [Abstract][Full Text] [Related]
17. An overview of the evolution of enterovirus 71 and its clinical and public health significance.
McMinn PC
FEMS Microbiol Rev; 2002 Mar; 26(1):91-107. PubMed ID: 12007645
[TBL] [Abstract][Full Text] [Related]
18. Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries.
Mirand A; Schuffenecker I; Henquell C; Billaud G; Jugie G; Falcon D; Mahul A; Archimbaud C; Terletskaia-Ladwig E; Diedrich S; Huemer HP; Enders M; Lina B; Peigue-Lafeuille H; Bailly JL
J Gen Virol; 2010 Sep; 91(Pt 9):2263-77. PubMed ID: 20505012
[TBL] [Abstract][Full Text] [Related]
19. Evidences for intertypic and intratypic recombinant events in EV71 of hand, foot and mouth disease during an epidemic in Hubei Province, China, 2011.
Li J; Huo X; Dai Y; Yang Z; Lei Y; Jiang Y; Li G; Zhan J; Zhan F
Virus Res; 2012 Oct; 169(1):195-202. PubMed ID: 22922556
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006.
Bible JM; Iturriza-Gomara M; Megson B; Brown D; Pantelidis P; Earl P; Bendig J; Tong CY
J Clin Microbiol; 2008 Oct; 46(10):3192-200. PubMed ID: 18650362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
